Profit-Influencing Factors in Orthopedic Surgery: An Analysis of Costs and Reimbursements.

Swiss DRG cost-benefit profitability analysis costing finance net financial result orthopedic surgery patient health data profit

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
04 04 2022
Historique:
received: 31 01 2022
revised: 30 03 2022
accepted: 31 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

The aging population and the associated demand for orthopedic surgeries are increasing health costs. Although the Diagnostic Related Groups (DRG) system was introduced to offer incentives for hospitals, concerns remain that reimbursements for older and frail patients do not cover all hospital expenses. We investigated further: (1) Does age influence net financial results in orthopedic surgery? (2) Are there patient or surgical factors that influence results? This retrospective, monocentric study compares costs and reimbursements for orthopedic patients in a tertiary care hospital in Switzerland between 2015 and 2017. The data of 1230 patients were analyzed. Overall, the net results for the hospital were positive, despite 19.5% of patients being treated at a loss. We did not find any correlation between age and profitability (p = 0.61). Patient-related factors associated with financial losses were female sex (p < 0.001) and diabetes (p = 0.013). Patients free of serious comorbidities (p = 0.012) or with a higher cost weight (p < 0.001) were more often profitable. A longer length of stay was associated with higher losses (p < 0.001). This is the first study to address the Swiss DRG reimbursement system in a broad orthopedic population, while also analyzing specific patient and surgical factors. Overall, the reimbursement system is fair, but could better account for certain interventions.

Identifiants

pubmed: 35410007
pii: ijerph19074325
doi: 10.3390/ijerph19074325
pmc: PMC8998626
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Arthroplasty. 2021 Aug;36(8):2680-2684
pubmed: 33840537
Health Econ. 2008 Jan;17(1 Suppl):S9-20
pubmed: 18186038
Health Res Policy Syst. 2010 Oct 16;8:31
pubmed: 20950481
BMC Health Serv Res. 2018 Jan 25;18(1):38
pubmed: 29370785
Clin Orthop Relat Res. 2020 Aug;478(8):1790-1800
pubmed: 32058435
Clin Orthop Relat Res. 2014 Dec;472(12):3943-50
pubmed: 25190193
J Bone Joint Surg Am. 2007 Apr;89(4):780-5
pubmed: 17403800
J Arthroplasty. 1998 Apr;13(3):296-8
pubmed: 9590641
Global Spine J. 2021 Apr;11(1_suppl):7S-13S
pubmed: 33890801
J Am Geriatr Soc. 2003 Mar;51(3):364-70
pubmed: 12588580
Atl Econ J. 2009 Sep 1;37(3):259-277
pubmed: 21625342
Intern Med J. 2013 Jul;43(7):767-71
pubmed: 23347364
J Arthroplasty. 2019 Jul;34(7S):S80-S83
pubmed: 30803802

Auteurs

Felix Rohrer (F)

Centre Hospitalier Universitaire Vaudois, CHUV, 1011 Lausanne, Switzerland.
Department of Internal Medicine, Sonnenhofspital, 3006 Bern, Switzerland.

Aresh Farokhnia (A)

Clinic for Immunology, University Hospital Zurich, 8091 Zurich, Switzerland.

Hubert Nötzli (H)

Orthopädie Sonnenhof, 3006 Bern, Switzerland.
Faculty of Medicine, University of Bern, 3012 Bern, Switzerland.

Frederik Haubitz (F)

PricewaterhouseCoopers AG, 8050 Zurich, Switzerland.

Tanja Hermann (T)

Stiftung Lindenhof, Campus SLB, Swiss Institute for Translational and Entrepreneurial Medicine, 3010 Bern, Switzerland.

Brigitta Gahl (B)

Clinical Trial Unit, University of Bern, 3012 Bern, Switzerland.

Andreas Limacher (A)

Clinical Trial Unit, University of Bern, 3012 Bern, Switzerland.

Jan Brügger (J)

Department of Internal Medicine, Sonnenhofspital, 3006 Bern, Switzerland.
Faculty of Medicine, University of Zurich, 8006 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH